Lyxumia could expedite moving patients to final drug dose

09/12/2011 | Bloomberg

A study of 482 patients with diabetes who used Sanofi's experimental Lyxumia found the drug improved blood-glucose levels when the dosage was doubled after two weeks or increased over three weeks, experts reported at the European Association for the Study of Diabetes conference. The drug, which also helped patients lose weight, could help doctors more quickly advance patients to the ideal drug dosing.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ